An official website of the United States government
PROSPR 1 Publications
According to PubMed, the publications listed below were funded at least in part by one or more of the following PROSPR 1 grants: U01CA163304 (Statistical Coordinating Center - Fred Hutchinson Cancer Research Center); U54CA163313 (Breast Research Site - University of Pennsylvania), U54CA163307 (Breast Research Site - Geisel School of Medicine, Dartmouth and Brigham and Women’s Hospital, Harvard University); U54CA163303 (Breast Research Site - University of Vermont); U54CA164336 (Cervical Research Site - University of New Mexico); 3U54CA163262-04S1 (Cervical Research Site - Kaiser Foundation Research Institute); 3U54CA163261-04S1 (Cervical Research Site - Group Health Research Institute); 3U54CA163308-04S1 (Cervical Research Site - Parkland UT Southwestern); U54CA163262 (Colorectal Research Site - Kaiser Foundation Research Institute), U54CA163261 (Colorectal Research Site - Group Health Research Institute); and U54CA163308 (Colorectal Research Site - Parkland UT Southwestern)
Abnet CC, Corley DA, Freedman ND, Kamangar F. Diet and upper gastrointestinal malignancies. Gastroenterology. 2015 May;148(6):1234-1243.e4. Epub 2015 Feb 11. doi: 10.1053/j.gastro.2015.02.007. [View Abstract
]
Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, et al. Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data. EGEMS (Wash DC). 2015 May 18;3(1):1171. doi: 10.13063/2327-9214.1171. [View Abstract]
Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, et al. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):938-944. Epub 2017 Jan 17. doi: 10.1158/1055-9965.EPI-16-0801. [View Abstract]
Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, et al. The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update. Med Decis Making. 2018 Apr;38(1_suppl):99S-111S. doi: 10.1177/0272989X17711927. [View Abstract]
Alagoz O, Hajjar A, Chootipongchaivat S, van Ravesteyn NT, Yeh JM, Ergun MA, et al. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study. J Gen Intern Med. 2019 Nov;34(11):2374-2381. Epub 2019 Aug 5. doi: 10.1007/s11606-019-05182-5. [View Abstract]
Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, et al. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. J Clin Oncol. 2019 Apr 20;37(12):954-963. Epub 2019 Jan 9. doi: 10.1200/JCO.18.00378. [View Abstract]
Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer. 2016 May 1;122(9):1338-42. Epub 2016 Feb 29. doi: 10.1002/cncr.29937. [View Abstract]
Atkins L, Hunkeler EM, Jensen CD, Michie S, Lee JK, Doubeni CA, et al. Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. Gastrointest Endosc. 2016 Mar;83(3):617-26.e2. Epub 2015 Sep 11. doi: 10.1016/j.gie.2015.08.075. [View Abstract]
Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, et al. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar;96(11):e6326. doi: 10.1097/MD.0000000000006326.[View Abstract]
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, et al. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 Mar 1;112(3):238-246. doi: 10.1093/jnci/djz137. [View Abstract]
Barnes A, Betts AC, Borton EK, Sanders JM, Pruitt SL, Werner C, et al. Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS. 2018 Aug 24;32(13):1861-1870. doi: 10.1097/QAD.0000000000001881. [View Abstract]
Barufaldi B, Schiabel H, Maidment ADA. Design and implementation of a radiation dose tracking and reporting system for mammography and digital breast tomosynthesis. Phys Med. 2019 Feb;58:131-140. Epub 2019 Feb 16. doi: 10.1016/j.ejmp.2019.02.011. [View Abstract]
Barufaldi B, Zuckerman SP, Medeiros RB, Maidment AD, Schiabel H. Characterization of the imaging settings in screening mammography using a tracking and reporting system: A multi-center and multi-vendor analysis. Phys Med. 2020 Mar;71:137-149. Epub 2020 Mar 3. doi: 10.1016/j.ejmp.2020.02.018. [View Abstract]
Baughman AW, Brawarsky P, Onega T, Tosteson TD, Wang Q, Tosteson AN, et al. Medical home transformation and breast cancer screening. Am J Manag Care. 2016 Nov 1;22(11):e382-e388. [View Abstract]
Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, et al. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015 May 7;107(6):djv120. doi: 10.1093/jnci/djv120. [View Abstract]
Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, et al. Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population. J Womens Health (Larchmt). 2019 Aug;28(8):1051-1059. Epub 2018 Nov 27. doi: 10.1089/jwh.2018.6997. [View Abstract]
Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, et al. Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium. Breast Cancer Res Treat. 2016 Nov;160(2):323-331. Epub 2016 Sep 24. doi: 10.1007/s10549-016-3990-x. [View Abstract]
Berge JM, Adamek M, Caspi C, Grannon KY, Loth KA, Trofholz A, et al. The Mastery Matrix for Integration Praxis: The development of a rubric for integration practice in addressing weight-related public health problems. Prev Med. 2018 Jun;111:78-86. Epub 2018 Feb 23. doi: 10.1016/j.ypmed.2018.02.024. [View Abstract]
Berkman A, F Cole B, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, et al. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2014 Nov;148(2):407-13. Epub 2014 Oct 18. doi: 10.1007/s10549-014-3168-3. [View Abstract]
Berkman AM, Trentham-Dietz A, Dittus K, Hart V, Vatovec CM, King JG, et al. Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes. Prev Med. 2015 Nov;80:53-9. Epub 2015 Apr 6. doi: 10.1016/j.ypmed.2015.03.020. [View Abstract]
Bissell MCS, Kerlikowske K, Sprague BL, Tice JA, Gard CC, Tossas KY, et al. Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status. Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):2048-2056. Epub 2020 Jul 29. doi: 10.1158/1055-9965.EPI-20-0358. [View Abstract]
Bitton A, Onega T, Tosteson AN, Haas JS. Toward a better understanding of patient-reported outcomes in clinical practice. Am J Manag Care. 2014 Apr;20(4):281-3. [View Abstract]
Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, et al. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Jun 23;106(8):dju157. doi: 10.1093/jnci/dju157. [View Abstract]
Bonafede MM, Miller JD, Pohlman SK, Troeger KA, Sprague BL, Herschorn SD, et al. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance. Am J Prev Med. 2019 Sep;57(3):394-402. Epub 2019 Aug 1. doi: 10.1016/j.amepre.2019.04.010. [View Abstract]
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Nov 22;31 Suppl 8(0 8):I1-31. doi: 10.1016/j.vaccine.2013.07.026. [View Abstract]
Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, et al. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642. [View Abstract]
Brawarsky P, Eibensteiner K, Klinger EV, Baer HJ, Getty G, Orav EJ, et al. Accuracy of self-perceived risk for common conditions. Cogent Med. 2018;5:1463894. Epub 2018 Apr 16. doi: 10.1080/2331205X.2018.1463894. [View Abstract]
Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, et al. Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type. Am J Prev Med. 2019 May;56(5):e143-e152. doi: 10.1016/j.amepre.2019.01.005. [View Abstract]
Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, et al. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549. [View Abstract]
Buist DSM, Ichikawa L, Wernli KJ, Lee CI, Henderson LM, Kerlikowske K, et al. Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization. J Am Coll Radiol. 2020 Jun;17(6):755-764. Epub 2020 Jan 28. doi: 10.1016/j.jacr.2019.12.020. [View Abstract]
Burger EA, Kim JJ. The value of improving failures within a cervical cancer screening program: an example from Norway. Int J Cancer. 2014 Oct 15;135(8):1931-9. Epub 2014 Mar 20. doi: 10.1002/ijc.28838. [View Abstract]
Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One. 2014 Mar 20;9(3):e89974. doi: 10.1371/journal.pone.0089974. [View Abstract]
Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, et al. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 Oct;51(4):e107-15. Epub 2016 Apr 1. doi: 10.1016/j.amepre.2016.02.025. [View Abstract]
Burnside ES, Lee SJ, Bennette C, Near AM, Alagoz O, Huang H, et al. Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age. MDM Policy Pract. 2017 Jul;2(2):2381468317717982. Epub 2017 Jul 8. doi: 10.1177/2381468317717982. [View Abstract]
Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, et al. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014 Sep 1;180(5):545-55. Epub 2014 Jul 31. doi: 10.1093/aje/kwu159. [View Abstract]
Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ. Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F157-67. doi: 10.1016/j.vaccine.2012.06.091. [View Abstract]
Carney PA, Allison KH, Oster NV, Frederick PD, Morgan TR, Geller BM, et al. Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation. Mod Pathol. 2016 Jul;29(7):717-26. Epub 2016 Apr 8. doi: 10.1038/modpathol.2016.62. [View Abstract]
Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ; New Mexico HPV Pap Registry Steering Committee. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Prev Med. 2018 Jun;111:177-179. Epub 2018 Mar 14. doi: 10.1016/j.ypmed.2018.03.011. [View Abstract]
Cevik M, Ergun MA, Stout NK, Trentham-Dietz A, Craven M, Alagoz O. Using Active Learning for Speeding up Calibration in Simulation Models. Med Decis Making. 2016 Jul;36(5):581-93. Epub 2015 Oct 15. doi: 10.1177/0272989X15611359. [View Abstract]
Chao C, Silverberg MJ, Becerra TA, Corley DA, Jensen CD, Chen Q, et al. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. Epub 2016 Oct 14. doi: 10.1016/j.ajog.2016.10.006. [View Abstract]
Chen JS, Sprague BL, Klabunde CN, Tosteson AN, Bitton A, Onega T, et al. Take the money and run? Redemption of a gift card incentive in a clinician survey. BMC Med Res Methodol. 2016 Feb 24;16:25. doi: 10.1186/s12874-016-0126-2. [View Abstract]
Chen L, Ray S, Keller BM, Pertuz S, McDonald ES, Conant EF, et al. The Impact of Acquisition Dose on Quantitative Breast Density Estimation with Digital Mammography: Results from ACRIN PA 4006. Radiology. 2016 Sep;280(3):693-700. Epub 2016 Mar 22. doi: 10.1148/radiol.2016151749. [View Abstract]
Chong A, Weinstein SP, McDonald ES, Conant EF. Digital Breast Tomosynthesis: Concepts and Clinical Practice. Radiology. 2019 Jul;292(1):1-14. Epub 2019 May 14. doi: 10.1148/radiol.2019180760. [View Abstract]
Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, et al. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470. [View Abstract]
Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016 Dec;23(4):179-185. Epub 2016 Mar 4. doi: 10.1177/0969141316630766. [View Abstract]
Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM. Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen. 2015 Jun;22(2):69-75. Epub 2014 Dec 9. doi: 10.1177/0969141314562036. [View Abstract]
Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, et al. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):91-98. Epub 2018 Nov 20. doi: 10.1158/1055-9965.EPI-18-0452. [View Abstract]
Chudgar AV, Conant EF, Weinstein SP, Keller BM, Synnestvedt M, Yamartino P, et al. Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone. Clin Radiol. 2017 Jul;72(7):573-579. Epub 2017 Mar 17. doi: 10.1016/j.crad.2017.02.013. [View Abstract]
Clark CR, Tosteson TD, Tosteson ANA, Onega T, Weiss JE, Harris KA, et al. Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type. Cancer Med. 2017 May;6(5):1102-1107. Epub 2017 Apr 4. doi: 10.1002/cam4.1036. [View Abstract]
Conant EF. Clinical implementation of digital breast tomosynthesis. Radiol Clin North Am. 2014 May;52(3):499-518. Epub 2014 Feb 18. doi: 10.1016/j.rcl.2013.11.013. [View Abstract]
Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, et al. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density. JAMA Oncol. 2019 May 1;5(5):635-642. doi: 10.1001/jamaoncol.2018.7078. [View Abstract]
Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat. 2016 Feb;156(1):109-16. Epub 2016 Mar 1. doi: 10.1007/s10549-016-3695-1. [View Abstract]
Conant EF, Keller BM, Pantalone L, Gastounioti A, McDonald ES, Kontos D. Agreement between Breast Percentage Density Estimations from Standard-Dose versus Synthetic Digital Mammograms: Results from a Large Screening Cohort Using Automated Measures. Radiology. 2017 Jun;283(3):673-680. Epub 2017 Jan 25. doi: 10.1148/radiol.2016161286. [View Abstract]
Conant EF, Sprague BL, Kontos D. Beyond BI-RADS Density: A Call for Quantification in the Breast Imaging Clinic. Radiology. 2018 Feb;286(2):401-404. doi: 10.1148/radiol.2017170644. [View Abstract]
Conant EF, Toledano AY, Periaswamy S, Fotin SV, Go J, Boatsman JE, et al. Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiol Artif Intell. 2019 Jul 31;1(4):e180096. doi: 10.1148/ryai.2019180096. [View Abstract]
Conant EF, Zuckerman SP, McDonald ES, Weinstein SP, Korhonen KE, Birnbaum JA, et al. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round. Radiology. 2020 May;295(2):285-293. Epub 2020 Mar 10. doi: 10.1148/radiol.2020191751. [View Abstract]
Conklin MW, Gangnon RE, Sprague BL, Van Gemert L, Hampton JM, Eliceiri KW, et al. Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ. Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):138-145. Epub 2017 Nov 15. doi: 10.1158/1055-9965.EPI-17-0720. [View Abstract]
Corley DA, Feigelson HS, Lieu TA, McGlynn EA. Building Data Infrastructure to Evaluate and Improve Quality: PCORnet. J Oncol Pract. 2015 May;11(3):204-6. doi: 10.1200/JOP.2014.003194 [View Abstract]
Corley DA, Haas JS, Kobrin S. Reducing Variation in the “Standard of Care” for Cancer Screening: Recommendations From the PROSPR Consortium. JAMA. 2016 May 17;315(19):2067-8. doi: 10.1001/jama.2016.3067. [View Abstract]
Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80. Epub 2012 Sep 14. doi: 10.1016/j.cgh.2012.09.010. [View Abstract]
Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306. doi: 10.1056/NEJMoa1309086. [View Abstract]
Corley DA, Jensen CD, Quinn VP, Doubeni CA, Zauber AG, Lee JK, et al. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25;317(16):1631-1641. doi: 10.1001/jama.2017.3634. [View Abstract]
Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, et al. A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):765-73. Epub 2013 Dec 3. doi: 10.1158/1055-9965.EPI-13-0973. [View Abstract]
Cuzick J, Myers O, Hunt WC, Saslow D, Castle PE, Kinney W, et al. Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management. Int J Cancer. 2015 Jun 15;136(12):2854-63. Epub 2014 Dec 1. doi: 10.1002/ijc.29337. [View Abstract]
Cuzick J, Myers O, Lee JH, Shi Y, Gage JC, Hunt WC, et al. Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing. JAMA Oncol. 2017 Oct 1;3(10):1327-1334. doi: 10.1001/jamaoncol.2017.1040. [View Abstract]
Daye D, Keller B, Conant EF, Chen J, Schnall MD, Maidment AD, et al. Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population. Acad Radiol. 2013 May;20(5):635-46. doi: 10.1016/j.acra.2012.12.016. [View Abstract]
Demb J, Abraham L, Miglioretti DL, Sprague BL, O'Meara ES, Advani S, et al. Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age. J Natl Cancer Inst. 2020 Jun 1;112(6):599-606. doi: 10.1093/jnci/djz172. [View Abstract]
Doubeni CA. The impact of colorectal cancer screening on the U.S. population: is it time to celebrate? Cancer. 2014 Sep 15;120(18):2810-3. Epub 2014 Jun 3. doi: 10.1002/cncr.28789. [View Abstract]
Doubeni CA. The Assessment of Potential Impact of Applications by Grant Review Panels. Epidemiology. 2016 May;27(3):314-5. doi: 10.1097/EDE.0000000000000452. [View Abstract]
Doubeni CA, Corley DA, Levin TR. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. JAMA. 2017 Aug 1;318(5):483. doi: 10.1001/jama.2017.9312. [View Abstract]
Doubeni CA, Corley DA, Zauber AG. Colorectal Cancer Health Disparities and the Role of U.S. Law and Health Policy. Gastroenterology. 2016 May;150(5):1052-1055. Epub 2016 Mar 24. doi: 10.1053/j.gastro.2016.03.012. [View Abstract]
Doubeni CA, Fedewa SA, Levin TR, Jensen CD, Saia C, Zebrowski AM, et al. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 Jan;156(1):63-74.e6. Epub 2018 Sep 27. doi: 10.1053/j.gastro.2018.09.040. [View Abstract]
Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, et al. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018 May;68(3):199-216. Epub 2018 Mar 30. doi: 10.3322/caac.21452. [View Abstract]
Doubeni CA, Jambaulikar GD, Fouayzi H, Robinson SB, Gunter MJ, Field TS, et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population--a retrospective cohort study. PLoS One. 2012;7(5):e36392. Epub 2012 May 2. doi: 10.1371/journal.pone.0036392. [View Abstract]
Doubeni CA, Jensen CD, Fedewa SA, Quinn VP, Zauber AG, Schottinger JE, et al. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 Nov 12;29(6):672-681. doi: 10.3122/jabfm.2016.06.160060. [View Abstract]
Durham DD, Roberts MC, Khan CP, Abraham LA, Smith RA, Kerlikowske K, et al. Age at initiation of screening mammography by family history of breast cancer in the breast cancer surveillance consortium. Cancer Causes Control. 2021 Jan;32(1):103-107. Epub 2020 Oct 24. doi: 10.1007/s10552-020-01354-5. [View Abstract]
Elmunzer BJ, Singal AG, Sussman JB, Deshpande AR, Sussman DA, Conte ML, et al. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc. 2015 Mar;81(3):700-709.e3. doi: 10.1016/j.gie.2014.10.033. [View Abstract]
Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K; Breast Cancer Surveillance Consortium. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017 Sep 1;3(9):1228-1236. Erratum in: JAMA Oncol. 2019 Nov 1;5(11):1643. doi: 10.1001/jamaoncol.2016.6326. [View Abstract]
Enwerem N, Cho MY, Demb J, Earles A, Heskett KM, Liu L, et al. Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal Adenoma. Clin Gastroenterol Hepatol. 2021 Apr;19(4):680-689.e12. Epub 2020 May 16. doi: 10.1016/j.cgh.2020.04.092. [View Abstract]
Evans MF, Vacek PM, Sprague BL, Stein GS, Stein JL, Weaver DL. Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels. J Cell Biochem. 2020 Feb;121(2):1736-1746. Epub 2019 Oct 8. doi: 10.1002/jcb.29409. [View Abstract]
Fedewa SA, Corley DA, Jensen CD, Zhao W, Goodman M, Jemal A, et al. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep;53(3):335-344. Epub 2017 Apr 17. doi: 10.1016/j.amepre.2017.02.018. [View Abstract]
Frederick PD, Nelson HD, Carney PA, Brunyé TT, Allison KH, Weaver DL, et al. The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making. Med Decis Making. 2017 Jan;37(1):91-100. Epub 2016 Apr 1. doi: 10.1177/0272989X16638326. [View Abstract]
Freer PE, Slanetz PJ, Haas JS, Tung NM, Hughes KS, Armstrong K, et al. Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel. Breast Cancer Res Treat. 2015 Sep;153(2):455-64. Epub 2015 Aug 20. doi: 10.1007/s10549-015-3534-9. [View Abstract]
Fujii MH, Herschorn SD, Sowden M, Hotaling EL, Vacek PM, Weaver DL, et al. Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study. AJR Am J Roentgenol. 2019 Mar;212(3):706-711. Epub 2019 Jan 23. doi: 10.2214/AJR.18.20255. [View Abstract]
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, et al. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstet Gynecol. 2016 Dec;128(6):1248-1257. doi: 10.1097/AOG.0000000000001721. [View Abstract]
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, et al. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):36-42. Epub 2015 Oct 30. doi: 10.1158/1055-9965.EPI-15-0669. [View Abstract]
Gastounioti A, Conant EF, Kontos D. Beyond breast density: a review on the advancing role of parenchymal texture analysis in breast cancer risk assessment. Breast Cancer Res. 2016 Sep 20;18(1):91. doi: 10.1186/s13058-016-0755-8. [View Abstract]
Gastounioti A, McCarthy AM, Pantalone L, Synnestvedt M, Kontos D, Conant EF. Effect of Mammographic Screening Modality on Breast Density Assessment: Digital Mammography versus Digital Breast Tomosynthesis. Radiology. 2019 May;291(2):320-327. Epub 2019 Mar 19. doi: 10.1148/radiol.2019181740. [View Abstract]
Gastounioti A, Oustimov A, Hsieh MK, Pantalone L, Conant EF, Kontos D. Using Convolutional Neural Networks for Enhanced Capture of Breast Parenchymal Complexity Patterns Associated with Breast Cancer Risk. Acad Radiol. 2018 Aug;25(8):977-984. Epub 2018 Feb 1. doi: 10.1016/j.acra.2017.12.025. [View Abstract]
Gastounioti A, Oustimov A, Keller BM, Pantalone L, Hsieh MK, Conant EF, et al. Breast parenchymal patterns in processed versus raw digital mammograms: A large population study toward assessing differences in quantitative measures across image representations. Med Phys. 2016 Nov;43(11):5862. doi: 10.1118/1.4963810. [View Abstract]
Ghai NR, Jensen CD, Corley DA, Doubeni CA, Schottinger JE, Zauber AG, et al. Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening. Clin Transl Gastroenterol. 2018 Sep 21;9(9):186. doi: 10.1038/s41424-018-0051-2. [View Abstract]
Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, et al. Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems. Cancer Prev Res (Phila). 2020 Nov;13(11):947-958. Epub 2020 Jul 15. doi: 10.1158/1940-6207.CAPR-20-0109. [View Abstract]
Gierach GL, Patel DA, Pfeiffer RM, Figueroa JD, Linville L, Papathomas D, et al. Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities. Cancer Prev Res (Phila). 2016 Feb;9(2):149-58. Epub 2015 Dec 8. doi: 10.1158/1940-6207.CAPR-15-0282. [View Abstract]
Golmakani MK, Hubbard RA, Miglioretti DL. Nonhomogeneous Markov chain for estimating the cumulative risk of multiple false positive screening tests. Biometrics. 2021 May 3. Epub ahead of print. doi: 10.1111/biom.13484. [View Abstract]
Goodrich ME, Weiss J, Onega T, Balch SL, Buist DS, Kerlikowske K, et al. The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women. Breast J. 2016 Nov;22(6):616-622. Epub 2016 Aug 23. doi: 10.1111/tbj.12651. [View Abstract]
Gould MK, Sakoda LC, Ritzwoller DP, Simoff MJ, Neslund-Dudas CM, Kushi LH, et al. Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec;14(12):1827-1835. doi: 10.1513/AnnalsATS.201703-237OC. [View Abstract]
Grady WM, Pritchard CC. Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol. 2014 Jan;42(1):124-39. Epub 2013 Oct 31. doi: 10.1177/0192623313505155. [View Abstract]
Green BB, Coronado GD, Devoe JE, Allison J. Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health. 2014 Jun;104(6):982-6. Epub 2014 Apr 17. doi: 10.2105/AJPH.2014.301877. [View Abstract]
Gupta S, Balasubramanian BA, Fu T, Genta RM, Rockey DC, Lash R. Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clin Gastroenterol Hepatol. 2012 Dec;10(12):1395-1401.e2. Epub 2012 Jul 24. doi: 10.1016/j.cgh.2012.07.004. [View Abstract]
Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013 Oct 14;173(18):1725-32. doi: 10.1001/jamainternmed.2013.9294. [View Abstract]
Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, et al. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. 2020 Feb;158(3):693-702. Epub 2019 Dec 6. doi: 10.1053/j.gastro.2019.12.003. [View Abstract]
Gupta S, Sun H, Yi S, Storm J, Xiao G, Balasubramanian BA, et al. Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study. Cancer Prev Res (Phila). 2014 Oct;7(10):1023-34. Epub 2014 Aug 4. doi: 10.1158/1940-6207.CAPR-14-0140. [View Abstract]
Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014 Apr;106(4):dju032. Epub 2014 Mar 28. doi: 10.1093/jnci/dju032. [View Abstract]
Gupta S, Tong L, Anderson P, Rose B, Carter E, Koch M, et al. Measurement of colorectal cancer test use with medical claims data in a safety-net health system. Am J Med Sci. 2013 Feb;345(2):99-103. doi: 10.1097/MAJ.0b013e31824dd1b6. [View Abstract]
Haas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ. Time to fecal immunochemical test completion for colorectal cancer screening. Am J Manag Care. 2019 Apr;25(4):174-180. [View Abstract]
Haas JS. The Complexity of Achieving the Promise of Precision Breast Cancer Screening. J Natl Cancer Inst. 2017 Jan 27;109(5):djw301. doi: 10.1093/jnci/djw301. [View Abstract]
Haas JS, Baer HJ, Eibensteiner K, Klinger EV, St Hubert S, Getty G, et al. A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care. Am J Prev Med. 2017 Jan;52(1):100-105. Epub 2016 Sep 14. doi: 10.1016/j.amepre.2016.07.013. [View Abstract]
Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, et al. Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients. J Gen Intern Med. 2017 Apr;32(4):449-457. Epub 2017 Jan 9. doi: 10.1007/s11606-016-3973-y. [View Abstract]
Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, et al. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15;122(4):611-7. Epub 2015 Dec 28. doi: 10.1002/cncr.29805. [View Abstract]
Haas JS, Kaplan CP. The Divide Between Breast Density Notification Laws and Evidence-Based Guidelines for Breast Cancer Screening: Legislating Practice. JAMA Intern Med. 2015 Sep;175(9):1439-40. doi: 10.1001/jamainternmed.2015.3040. [View Abstract]
Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, et al. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med. 2016 Jan;31(1):52-9. doi: 10.1007/s11606-015-3449-5. [View Abstract]
Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, et al. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 Oct;31(10):1190-7. Epub 2016 Jun 8. doi: 10.1007/s11606-016-3760-9. [View Abstract]
Hart V, Reeves KW, Sturgeon SR, Reich NG, Sievert LL, Kerlikowske K, et al. The effect of change in body mass index on volumetric measures of mammographic density. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1724-30. Epub 2015 Aug 27. doi: 10.1158/1055-9965.EPI-15-0330. [View Abstract]
Hart V, Sprague BL, Lakoski SG, Hampton JM, Newcomb PA, Gangnon RE, et al. Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ. J Clin Oncol. 2016 Apr 20;34(12):1323-9. Epub 2016 Feb 16. Erratum in: J Clin Oncol. 2016 Aug 20;34(24):2943. doi: 10.1200/JCO.2015.62.7281. [View Abstract]
Hart V, Trentham-Dietz A, Berkman A, Fujii M, Veal C, Hampton J, et al. The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study. Qual Life Res. 2018 May;27(5):1237-1247. Epub 2018 Feb 7. doi: 10.1007/s11136-018-1807-6. [View Abstract]
Henderson LM, Hubbard RA, Sprague BL, Zhu W, Kerlikowske K. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram. Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1882-9. doi: 10.1158/1055-9965.EPI-15-0623. [View Abstract]
Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, et al. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 Oct;34(10):2098-2106. Epub 2019 Aug 13. doi: 10.1007/s11606-019-05181-6. [View Abstract]
Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep;205(3):676-84. doi: 10.2214/AJR.14.13904. [View Abstract]
Henderson LM, O'Meara ES, Braithwaite D, Onega T; Breast Cancer Surveillance Consortium. Performance of digital screening mammography among older women in the United States. Cancer. 2015 May 1;121(9):1379-86. Epub 2014 Dec 23. doi: 10.1002/cncr.29214. [View Abstract]
Henderson LM, O'Meara ES, Haas JS, Lee CI, Kerlikowske K, Sprague BL, et al. The Role of Social Determinants of Health in Self-Reported Access to Health Care Among Women Undergoing Screening Mammography. J Womens Health (Larchmt). 2020 Nov;29(11):1437-1446. Epub 2020 May 5. doi: 10.1089/jwh.2019.8267. [View Abstract]
Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, et al. Utilization of breast cancer screening with magnetic resonance imaging in community practice. J Gen Intern Med. 2018 Mar;33(3):275-283. Epub 2017 Dec 6. doi: 10.1007/s11606-017-4224-6. [View Abstract]
Hillyer GC, Jensen CD, Zhao WK, Neugut AI, Lebwohl B, Tiro JA, et al. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 1;123(19):3744-3753. Epub 2017 Jun 16. doi: 10.1002/cncr.30809. [View Abstract]
Hubbard R, Chubak J, Rutter C. Estimating screening test utilization using electronic health records data. EGEMS (Wash DC). 2014 Nov 4;2(1):14. doi: 10.13063/2327-9214.1109. [View Abstract]
Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, et al. Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol. 2017 Jun;17(2):101-112. Epub 2016 Jun 3. doi: 10.1007/s10742-016-0149-5. [View Abstract]
Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, et al. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 Aug;89:169-177. Epub 2016 May 31. doi: 10.1016/j.ypmed.2016.05.034. [View Abstract]
Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):513-20. Epub 2015 Dec 31. doi: 10.1158/1055-9965.EPI-15-0824. [View Abstract]
Hughes AE, Pruitt SL. The utility of EMR address histories for assessing neighborhood exposures. Ann Epidemiol. 2017 Jan;27(1):20-26. Epub 2016 Aug 20. doi: 10.1016/j.annepidem.2016.07.016. [View Abstract]
Hughes AE, Tiro JA, Balasubramanian BA, Skinner CS, Pruitt SL. Social Disadvantage, Healthcare Utilization, and Colorectal Cancer Screening: Leveraging Longitudinal Patient Address and Health Records Data. Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1424-1432. Epub 2018 Aug 22. doi: 10.1158/1055-9965.EPI-18-0446. [View Abstract]
Jackson SL, Frederick PD, Pepe MS, Nelson HD, Weaver DL, Allison KH, et al. Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time? Ann Surg Oncol. 2017 May;24(5):1234-1241. Epub 2016 Dec 2. doi: 10.1245/s10434-016-5695-0. [View Abstract]
James TA, Wade JE, Sprague BL. The impact of mammographic screening on the surgical management of breast cancer. J Surg Oncol. 2016 Apr;113(5):496-500. Epub 2016 Jan 22. doi: 10.1002/jso.24184. [View Abstract]
Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, et al. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 5;164(7):456-63. Epub 2016 Jan 26. doi: 10.7326/M15-0983. [View Abstract]
Jensen CD, Doubeni CA, Quinn VP, Levin TR, Zauber AG, Schottinger JE, et al. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr;13(4):739-46. Epub 2014 Oct 25. doi: 10.1016/j.cgh.2014.10.020. [View Abstract]
Johnson A, Shulman L, Kachajian J, Sprague BL, Khan F, James T, et al. Access to Care in Vermont: Factors Linked With Time to Chemotherapy for Women With Breast Cancer-A Retrospective Cohort Study. J Oncol Pract. 2016 Sep;12(9):e848-57. Epub 2016 Aug 30. doi: 10.1200/JOP.2016.013409. [View Abstract]
Johnson KE, Kamineni A, Fuller S, Olmstead D, Wernli KJ. How the provenance of electronic health record data matters for research: a case example using system mapping. EGEMS (Wash DC). 2014 Apr 16;2(1):1058. doi: 10.13063/2327-9214.1058. [View Abstract]
Kahn B, Freeland Z, Gopal P, Agrawal D, Mayorga CA, Mithani R, et al. Predictors of guideline concordance for surveillance colonoscopy recommendations in patients at a safety-net health system. Cancer Causes Control. 2015 Nov;26(11):1653-60. Epub 2015 Sep 16. doi: 10.1007/s10552-015-0661-x. [View Abstract]
Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, et al. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a U.S. cohort. Int J Cancer. 2019 Mar 15;144(6):1460-1473. Epub 2018 Dec 20. doi: 10.1002/ijc.31940. [View Abstract]
Keller BM, Chen J, Conant EF, Kontos D. Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer. Proc SPIE Int Soc Opt Eng. 2014 Mar 27;9035:90351D. doi: 10.1117/12.2043710. [View Abstract]
Keller BM, Chen J, Daye D, Conant EF, Kontos D. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography. Breast Cancer Res. 2015 Aug 25;17:117. doi: 10.1186/s13058-015-0626-8. [View Abstract]
Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, et al. Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography. BMC Cancer. 2015 Mar 18;15:143. doi: 10.1186/s12885-015-1159-3. [View Abstract]
Keller BM, Nathan DL, Gavenonis SC, Chen J, Conant EF, Kontos D. Reader variability in breast density estimation from full-field digital mammograms: the effect of image postprocessing on relative and absolute measures. Acad Radiol. 2013 May;20(5):560-8. Epub 2013 Mar 5. doi: 10.1016/j.acra.2013.01.003. [View Abstract]
Keller BM, Nathan DL, Wang Y, Zheng Y, Gee JC, Conant EF, et al. Estimation of breast percent density in raw and processed full field digital mammography images via adaptive fuzzy c-means clustering and support vector machine segmentation. Med Phys. 2012 Aug;39(8):4903-17. doi: 10.1118/1.4736530. [View Abstract]
Keller BM, Oustimov A, Wang Y, Chen J, Acciavatti RJ, Zheng Y, et al. Parenchymal texture analysis in digital mammography: robust texture feature identification and equivalence across devices. J Med Imaging (Bellingham). 2015 Apr;2(2):024501. Epub 2015 Apr 3. doi: 10.1117/1.JMI.2.2.024501. [View Abstract]
Kemp Jacobsen K, Abraham L, Buist DS, Hubbard RA, O'Meara ES, Sprague BL, et al. Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. Cancer Epidemiol. 2015 Aug;39(4):656-63. Epub 2015 May 23. doi: 10.1016/j.canep.2015.05.004. [View Abstract]
Kemp Jacobsen K, O'Meara ES, Key D, S M Buist D, Kerlikowske K, Vejborg I, et al. Comparing sensitivity and specificity of screening mammography in the United States and Denmark. Int J Cancer. 2015 Nov 1;137(9):2198-207. Epub 2015 Jun 1. doi: 10.1002/ijc.29593. [View Abstract]
Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL; Breast Cancer Surveillance Consortium. One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):889-97. Epub 2015 Mar 30. doi: 10.1158/1055-9965.EPI-15-0035. [View Abstract]
Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL; Breast Cancer Surveillance Consortium. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer. J Natl Cancer Inst. 2016 Dec 31;109(5):djw276. doi: 10.1093/jnci/djw276. [View Abstract]
Kerlikowske K, Ma L, Scott CG, Mahmoudzadeh AP, Jensen MR, Sprague BL, et al. Combining quantitative and qualitative breast density measures to assess breast cancer risk. Breast Cancer Res. 2017 Aug 22;19(1):97. doi: 10.1186/s13058-017-0887-5. [View Abstract]
Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015 May 19;162(10):673-81. doi: 10.7326/M14-1465. [View Abstract]
Khadanga S, Lakoski SG, Hart V, Sprague BL, Ba Y, Hampton JM, et al. Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):76-82. Epub 2015 Nov 6. doi: 10.1158/1055-9965.EPI-15-0726. [View Abstract]
Khatami S, Xuan L, Roman R, Zhang S, McConnel C, Halm EA, et al. Modestly increased use of colonoscopy when copayments are waived. Clin Gastroenterol Hepatol. 2012 Jul;10(7):761-766.e1. Epub 2012 Mar 5. doi: 10.1016/j.cgh.2012.02.027. [View Abstract]
Kim JJ. Practice-based evidence for primary HPV testing in the United States. J Natl Cancer Inst. 2014 Jul 18;106(8):dju213. doi: 10.1093/jnci/dju213. [View Abstract]
Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, et al. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med. 2015 Oct 20;163(8):589-97. Epub 2015 Sep 29. doi: 10.7326/M15-0420. [View Abstract]
Kim JJ, Sharma M, Ortendahl J. Optimal interval for routine cytologic screening in the United States. JAMA Intern Med. 2013 Feb 11;173(3):241-2. doi: 10.1001/2013.jamainternmed.1034. [View Abstract]
Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, et al. Cancer Models and Real-world Data: Better Together. J Natl Cancer Inst. 2015 Nov 3;108(2):djv316. doi: 10.1093/jnci/djv316. [View Abstract]
Kinney W, Hunt WC, Dinkelspiel H, Robertson M, Cuzick J, Wheeler CM; New Mexico HPV Pap Registry Steering Committee. Cervical excisional treatment of young women: a population-based study. Gynecol Oncol. 2014 Mar;132(3):628-35. Epub 2014 Jan 4. doi: 10.1016/j.ygyno.2013.12.037. [View Abstract]
Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, et al. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 Sep;51(3):e67-75. Epub 2016 Jun 22. doi: 10.1016/j.amepre.2016.04.018. [View Abstract]
Klinger EV, Kaplan CP, St Hubert S, Birdwell RL, Haas JS. Patient and Provider Perspectives on Mammographic Breast Density Notification Legislation. MDM Policy Pract. 2016 Nov 17;1(1):2381468316680620. doi: 10.1177/2381468316680620. [View Abstract]
Knerr S, Bowles EJA, Leppig KA, Buist DSM, Gao H, Wernli KJ. Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015. J Natl Cancer Inst. 2019 Aug 1;111(8):795-802. doi: 10.1093/jnci/djz008. [View Abstract]
Knerr S, Wernli KJ, Leppig K, Ehrlich K, Graham AL, Farrell D, et al. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017 May;56:25-33. Epub 2017 Feb 28. doi: 10.1016/j.cct.2017.02.009. [View Abstract]
Kontos D, Winham SJ, Oustimov A, Pantalone L, Hsieh MK, Gastounioti A,, et al. Radiomic Phenotypes of Mammographic Parenchymal Complexity: Toward Augmenting Breast Density in Breast Cancer Risk Assessment. Radiology. 2019 Jan;290(1):41-49. Epub 2018 Oct 30. doi: 10.1148/radiol.2018180179. [View Abstract]
Korhonen KE, Conant EF, Cohen EA, Synnestvedt M, McDonald ES, Weinstein SP. Breast Cancer Conspicuity on Simultaneously Acquired Digital Mammographic Images versus Digital Breast Tomosynthesis Images. Radiology. 2019 Jul;292(1):69-76. Epub 2019 May 14. doi: 10.1148/radiol.2019182027. [View Abstract]
Korhonen KE, Weinstein SP, McDonald ES, Conant EF. Strategies to Increase Cancer Detection: Review of True-Positive and False-Negative Results at Digital Breast Tomosynthesis Screening. Radiographics. 2016 Nov-Dec;36(7):1954-1965. Epub 2016 Oct 7. doi: 10.1148/rg.2016160049. [View Abstract]
Lacson R, Goodrich ME, Harris K, Brawarsky P, Haas JS. Assessing Inaccuracies in Automated Information Extraction of Breast Imaging Findings. J Digit Imaging. 2017 Apr;30(2):228-233. doi: 10.1007/s10278-016-9927-4. [View Abstract]
Lacson R, Harris K, Brawarsky P, Tosteson TD, Onega T, Tosteson AN, et al. Evaluation of an Automated Information Extraction Tool for Imaging Data Elements to Populate a Breast Cancer Screening Registry. J Digit Imaging. 2015 Oct;28(5):567-75. doi: 10.1007/s10278-014-9762-4. [View Abstract]
Landy R, Mathews C, Robertson M, Wiggins CL, McDonald YJ, Goldberg DW, et al. A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States. Gynecol Oncol. 2020 Nov;159(2):344-353. Epub 2020 Sep 22. Erratum in: Gynecol Oncol. 2021 Jun;161(3):913. doi: 10.1016/j.ygyno.2020.08.033. [View Abstract]
Landy R, Mathews C, Robertson M, Wiggins CL, McDonald YJ, Goldberg DW, et al. Erratum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353]. Gynecol Oncol. 2021 Jun;161(3):913. Epub 2021 Apr 15. Erratum for: Gynecol Oncol. 2020 Nov;159(2):344-353. doi: 10.1016/j.ygyno.2021.04.009. [View Abstract]
Landy R, Sasieni PD, Mathews C, Wiggins CL, Robertson M, McDonald YJ, et al. Impact of screening on cervical cancer incidence: A population-based case-control study in the United States. Int J Cancer. 2020 Aug 1;147(3):887-896. Epub 2019 Dec 31. doi: 10.1002/ijc.32826. [View Abstract]
Lee A, Jensen CD, Marks AR, Zhao WK, Doubeni CA, Zauber AG, et al. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. Gastrointest Endosc. 2017 Mar;85(3):601-610.e2. Epub 2016 Oct 1. doi: 10.1016/j.gie.2016.09.033. [View Abstract]
Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, et al. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan;206(1):211-6. doi: 10.2214/AJR.15.14356. [View Abstract]
Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, et al. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 2015 Mar;274(3):772-80. Epub 2014 Oct 28. doi: 10.1148/radiol.14141237. [View Abstract]
Lee CI, Zhu W, Onega T, Henderson LM, Kerlikowske K, Sprague BL, et al. Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status. JAMA Netw Open. 2021 Feb 1;4(2):e2037546. doi: 10.1001/jamanetworkopen.2020.37546. [View Abstract]
Lee JK, Corley DA. What makes a "good" colonoscopy quality indicator? Gastrointest Endosc. 2016 Jan;83(1):179-81. doi: 10.1016/j.gie.2015.06.052. [View Abstract]
Lee JK, Jensen CD, Lee A, Doubeni CA, Zauber AG, Levin TR, et al. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar;81(3):575-582.e4. Epub 2015 Jan 8. doi: 10.1016/j.gie.2014.07.031. [View Abstract]
Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, et al. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 Mar;158(4):884-894.e5. Epub 2019 Oct 4. Erratum in: Gastroenterology. 2021 Mar;160(4):1433. doi: 10.1053/j.gastro.2019.09.039. [View Abstract]
Lee JK, Jensen CD, Levin TR, Zauber AG, Doubeni CA, Zhao WK, et al. Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing. J Clin Gastroenterol. 2019 Jan;53(1):e25-e30. doi: 10.1097/MCG.0000000000000929. [View Abstract]
Lee JK, Jensen CD, Levin TR, Zauber AG, Schottinger JE, Quinn VP, et al. Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings. JAMA Intern Med. 2019 Feb 1;179(2):153-160. doi: 10.1001/jamainternmed.2018.5565. [View Abstract]
Lee JK, Levin TR, Corley DA. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol. 2013 Mar;11(3):204-7. doi: 10.1016/j.cgh.2012.12.014. [View Abstract]
Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 4;160(3):171. doi: 10.7326/M13-1484. [View Abstract]
Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, et al. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol. 2018 Jul 10;36(20):2070-2077. Epub 2018 May 2. doi: 10.1200/JCO.2017.76.8267. [View Abstract]
Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, et al. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 Oct;285(1):44-52. Epub 2017 Jun 5. doi: 10.1148/radiol.2017162033. [View Abstract]
Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, et al. Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016. Radiology. 2021 Aug;300(2):290-300. Epub 2021 May 18. doi: 10.1148/radiol.2021204581. [View Abstract]
Lee SJ, Li X, Huang H, Zelen M. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update. Med Decis Making. 2018 Apr;38(1_suppl):44S-53S. doi: 10.1177/0272989X17741634. [View Abstract]
Lee SJC, Inrig SJ, Balasubramanian BA, Skinner CS, Higashi RT, McCallister K, et al. Identifying quality improvement targets to facilitate colorectal cancer screening completion. Prev Med Rep. 2018 Feb 2;9:138-143. doi: 10.1016/j.pmedr.2018.01.004. [View Abstract]
Lee SJC, Murphy CC, Geiger AM, Gerber DE, Cox JV, Nair R, et al. Conceptual Model for Accrual to Cancer Clinical Trials. J Clin Oncol. 2019 Aug 10;37(23):1993-1996. Epub 2019 Jun 5. doi: 10.1200/JCO.19.00101. [View Abstract]
Lee SJC, Murphy CC, Gerber DE, Geiger AM, Halm E, Nair RG, et al. Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual. Med Care. 2021 May 1;59(5):461-466. doi: 10.1097/MLR.0000000000001509. [View Abstract]
Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 Apr;283(1):49-58. Epub 2016 Dec 5. doi: 10.1148/radiol.2016161174. [View Abstract]
Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL; Breast Cancer Surveillance Consortium. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. JAMA Intern Med. 2015 Nov;175(11):1828-37. doi: 10.1001/jamainternmed.2015.5231. [View Abstract]
Leopold RB, Thomas AW, Concannon KF, Correll AD, LaPenta CM, Maurer SM, et al. Breast cancer screening in patients with cancers other than breast. Breast Cancer Res Treat. 2017 Jun;163(2):343-348. Epub 2017 Mar 6. doi: 10.1007/s10549-017-4179-7. [View Abstract]
Levin TR, Corley DA, Jensen CD, Marks AR, Zhao WK, Zebrowski AM, et al. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 Mar;62(3):678-688. Epub 2017 Jan 2. doi: 10.1007/s10620-016-4433-6. [View Abstract]
Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, et al. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 Nov;155(5):1383-1391.e5. Epub 2018 Jul 19. doi: 10.1053/j.gastro.2018.07.017. [View Abstract]
Levin TR, Jensen CD, Chawla NM, Sakoda LC, Lee JK, Zhao WK, et al. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 Nov;159(5):1695-1704.e1. Epub 2020 Jul 20. doi: 10.1053/j.gastro.2020.07.011. [View Abstract]
Li D, Udaltsova N, Layefsky E, Doan C, Corley DA. Natural Language Processing for the Accurate Identification of Colorectal Cancer Mismatch Repair Status in Lynch Syndrome Screening. Clin Gastroenterol Hepatol. 2021 Mar;19(3):610-612.e1. Epub 2020 Feb 7. doi: 10.1016/j.cgh.2020.01.040. [View Abstract]
Lowry KP, Coley RY, Miglioretti DL, Kerlikowske K, Henderson LM, Onega T, et al. Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density. JAMA Netw Open. 2020 Jul 1;3(7):e2011792. doi: 10.1001/jamanetworkopen.2020.11792. [View Abstract]
Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, et al. Long-Term Outcomes and Cost-Effectiveness of Breast Cancer Screening With Digital Breast Tomosynthesis in the United States. J Natl Cancer Inst. 2020 Jun 1;112(6):582-589. doi: 10.1093/jnci/djz184. [View Abstract]
Magrath M, Yang E, Ahn C, Mayorga CA, Gopal P, Murphy CC, et al. Impact of a Clinical Decision Support System on Guideline Adherence of Surveillance Recommendations for Colonoscopy After Polypectomy. J Natl Compr Canc Netw. 2018 Nov;16(11):1321-1328. doi: 10.6004/jnccn.2018.7050. [View Abstract]
Mahorter SS, Knerr S, Bowles EJA, Wernli KJ, Gao H, Schwartz MD, et al. Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial. Cancer. 2020 Apr 15;126(8):1614-1621. Epub 2020 Jan 24. doi: 10.1002/cncr.32711. [View Abstract]
Mandelblatt JS, Near AM, Miglioretti DL, Munoz D, Sprague BL, Trentham-Dietz A, et al. Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling. Med Decis Making. 2018 Apr;38(1_suppl):9S-23S. doi: 10.1177/0272989X17700624. [View Abstract]
Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, et al. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med. 2016 Feb 16;164(4):215-25. Epub 2016 Jan 12. doi: 10.7326/M15-1536. [View Abstract]
Mandelblatt JS, Tosteson AN, van Ravesteyn NT. Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control. JAMA Intern Med. 2013 Feb 11;173(3):227-8. doi: 10.1001/jamainternmed.2013.2127. [View Abstract]
Marks AR, Pietrofesa RA, Jensen CD, Zebrowski A, Corley DA, Doubeni CA. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1692-8. Epub 2015 Sep 16. doi: 10.1158/1055-9965.EPI-15-0559. [View Abstract]
Marquez E, Geng Z, Pass S, Summerour P, Robinson L, Sarode V, et al. Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges. Genet Med. 2013 Dec;15(12):925-32. Epub 2013 Apr 18. doi: 10.1038/gim.2013.45. [View Abstract]
Martin J, Halm EA, Tiro JA, Merchant Z, Balasubramanian BA, McCallister K, et al. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med. 2017 Jan;130(1):93.e1-93.e7.Epub 2016 Aug 31. doi: 10.1016/j.amjmed.2016.07.028. [View Abstract]
McCarthy AM, Armstrong K. The role of testing for BRCA1 and BRCA2 mutations in cancer prevention. JAMA Intern Med. 2014 Jul;174(7):1023-4. doi: 10.1001/jamainternmed.2014.1322. [View Abstract]
McCarthy AM, Barlow WE, Conant EF, Haas JS, Li CI, Sprague BL, et al. Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative Results. JAMA Oncol. 2018 Jul 1;4(7):998-1001. Erratum in: JAMA Oncol. 2018 Jul 1;4(7):1018. doi: 10.1001/jamaoncol.2018.0352. [View Abstract]
McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, et al. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms. Breast Cancer Res. 2015 Jan 8;17(1):1. doi: 10.1186/s13058-014-0509-4. [View Abstract]
McCarthy AM, Keller BM, Pantalone LM, Hsieh MK, Synnestvedt M, Conant EF, et al. Racial Differences in Quantitative Measures of Area and Volumetric Breast Density. J Natl Cancer Inst. 2016 Apr 29;108(10):djw104. doi: 10.1093/jnci/djw104. [View Abstract]
McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, et al. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med. 2016 Oct;51(4):507-12. Epub 2016 Apr 28. doi: 10.1016/j.amepre.2016.03.017. [View Abstract]
McCarthy AM, Kontos D, Synnestvedt M, Tan KS, Heitjan DF, Schnall M, et al. Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. J Natl Cancer Inst. 2014 Oct 13;106(11):dju316. doi: 10.1093/jnci/dju316. [View Abstract]
McCarthy AM, Yamartino P, Yang J, Bristol M, Conant EF, Armstrong K. Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST). Med Care. 2015 Aug;53(8):673-8. doi: 10.1097/MLR.0000000000000393. [View Abstract]
McCarthy AM, Yang J, Armstrong K. Increasing disparities in breast cancer mortality from 1979 to 2010 for U.S. black women aged 20 to 49 years. Am J Public Health. 2015 Jul;105 Suppl 3(Suppl 3):S446-8. Epub 2015 Apr 23. doi: 10.2105/AJPH.2014.302297. [View Abstract]
McDonald ES, McCarthy AM, Akhtar AL, Synnestvedt MB, Schnall M, Conant EF. Baseline Screening Mammography: Performance of Full-Field Digital Mammography Versus Digital Breast Tomosynthesis. AJR Am J Roentgenol. 2015 Nov;205(5):1143-8. doi: 10.2214/AJR.15.14406. [View Abstract]
McDonald ES, McCarthy AM, Weinstein SP, Schnall MD, Conant EF. BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis. Radiology. 2017 Dec;285(3):778-787. Epub 2017 Jul 17. doi: 10.1148/radiol.2017162837. [View Abstract]
McDonald YJ, Goldberg DW, Scarinci IC, Castle PE, Cuzick J, Robertson M, et al. Health Service Accessibility and Risk in Cervical Cancer Prevention: Comparing Rural Versus Nonrural Residence in New Mexico. J Rural Health. 2017 Sep;33(4):382-392. Epub 2016 Aug 24. doi: 10.1111/jrh.12202. [View Abstract]
McDonald YJ, Schwind M, Goldberg DW, Lampley A, Wheeler CM. An analysis of the process and results of manual geocode correction. Geospat Health. 2017 May 11;12(1):526. doi: 10.4081/gh.2017.526. [View Abstract]
McLaughlin VH, Trentham-Dietz A, Hampton JM, Newcomb PA, Sprague BL. Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):450-60. Epub 2014 Jan 8. doi: 10.1158/1055-9965.EPI-13-0899. [View Abstract]
Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Goede SL, Levin TR, Quinn VP, et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar;25(3):208-213.e1. Epub 2014 Dec 5. doi: 10.1016/j.annepidem.2014.11.011. [View Abstract]
Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Jensen CD, van der Meulen MP, Levin TR, et al. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. JAMA. 2015 Jun 16;313(23):2349-58. doi: 10.1001/jama.2015.6251. [View Abstract]
Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 1;121(13):2281-5. Epub 2015 Mar 12. doi: 10.1002/cncr.29336. [View Abstract]
Meester RG, Zauber AG, Doubeni CA, Jensen CD, Quinn VP, Helfand M, et al. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1445-1451.e8. Epub 2016 May 19. Erratum in: Clin Gastroenterol Hepatol. 2018 May;16(5):787. Erratum in: Clin Gastroenterol Hepatol. 2018 Aug;16(8):1365. Abstract corrected. doi: 10.1016/j.cgh.2016.05.017. [View Abstract]
Meester RGS, Doubeni CA, Zauber AG, van Ballegooijen M, Corley DA, Lansdorp-Vogelaar I. Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer. Int J Cancer. 2017 Dec 1;141(11):2359-2367. Epub 2017 Aug 31. doi: 10.1002/ijc.30933. [View Abstract]
Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester R, et al. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016 Nov;31(11):1323-1330. Epub 2016 Jul 13. doi: 10.1007/s11606-016-3792-1. [View Abstract]
Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL. Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy. JAMA Oncol. 2017 Jan 1;3(1):36-41. doi: 10.1001/jamaoncol.2016.3022. [View Abstract]
Miglioretti DL, Abraham L, Lee CI, Buist DSM, Herschorn SD, Sprague BL, et al. Digital Breast Tomosynthesis: Radiologist Learning Curve. Radiology. 2019 Apr;291(1):34-42. Epub 2019 Feb 26. doi: 10.1148/radiol.2019182305. [View Abstract]
Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, et al. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Netw Open. 2021 Mar 1;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. [View Abstract]
Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, et al. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann Intern Med. 2016 Feb 16;164(4):205-14. Epub 2016 Jan 12. doi: 10.7326/M15-1241. [View Abstract]
Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, et al. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol. 2015 Nov;1(8):1069-77. doi: 10.1001/jamaoncol.2015.3084. [View Abstract]
Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, et al. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 Jun;27(6):748-754. Epub 2018 Jan 17. doi: 10.1089/jwh.2017.6623. [View Abstract]
Munoz DF, Plevritis SK. Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment. Med Decis Making. 2018 Apr;38(1_suppl):32S-43S. doi: 10.1177/0272989X17743236. [View Abstract]
Murphy CC, Ahn C, Pruitt SL, Hughes AE, Halm EA, Gupta S, et al. Screening initiation with FIT or colonoscopy: Post-hoc analysis of a pragmatic, randomized trial. Prev Med. 2019 Jan;118:332-335. Epub 2018 Dec 1. doi: 10.1016/j.ypmed.2018.11.020. [View Abstract]
Murphy CC, Halm EA, Skinner CS, Balasubramanian BA, Singal AG. Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1557-1563. Epub 2020 May 26. doi: 10.1158/1055-9965.EPI-20-0230. [View Abstract]
Murphy CC, Sigel BM, Yang E, Skinner CS, Halm EA, Gupta S, et al. Adherence to colorectal cancer screening measured as the proportion of time covered. Gastrointest Endosc. 2018 Aug;88(2):323-331.e2. Epub 2018 Feb 23. doi: 10.1016/j.gie.2018.02.023. [View Abstract]
Murphy CC, Vernon SW, Diamond PM, Tiro JA. Competitive testing of health behavior theories: how do benefits, barriers, subjective norm, and intention influence mammography behavior? Ann Behav Med. 2014 Feb;47(1):120-9. doi: 10.1007/s12160-013-9528-0. [View Abstract]
Murray MF, Giovanni MA, Klinger E, George E, Marinacci L, Getty G, et al. Comparing electronic health record portals to obtain patient-entered family health history in primary care. J Gen Intern Med. 2013 Dec;28(12):1558-64. Epub 2013 Apr 16. doi: 10.1007/s11606-013-2442-0. [View Abstract]
Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti D. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 2016 Feb 16;164(4):226-35. Epub 2016 Jan 12. doi: 10.7326/M15-0971. [View Abstract]
Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, et al. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer. 2014 Oct 1;120(19):2955-64. Epub 2014 May 15. doi: 10.1002/cncr.28771. [View Abstract]
Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, et al. Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns. Am J Manag Care. 2017 Jan;23(1):35-40. [View Abstract]
Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, et al. Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related? J Am Coll Radiol. 2016 Jun;13(6):611-9. Epub 2016 Mar 22. doi: 10.1016/j.jacr.2016.01.022. [View Abstract]
Onega T, Tosteson TD, Weiss J, Haas JS, Goodrich M, DiFlorio R, et al. Multi-level Influences on Breast Cancer Screening in Primary Care. J Gen Intern Med. 2018 Oct;33(10):1729-1737. Epub 2018 Aug 3. doi: 10.1007/s11606-018-4560-1. [View Abstract]
Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, et al. The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer. 2017 Jul;80:39-47. Epub 2017 May 20. doi: 10.1016/j.ejca.2017.04.013. [View Abstract]
Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, et al. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec;116(8):1008-1015. Epub 2017 Nov 11. doi: 10.1002/jso.24796. [View Abstract]
Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, et al. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat. 2018 Jul;170(1):149-157. Epub 2018 Mar 7. doi: 10.1007/s10549-018-4732-z. [View Abstract]
Othman E, Wang J, Sprague BL, Rounds T, Ji Y, Herschorn SD, et al. Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules. Springerplus. 2015 Feb 13;4:77. doi: 10.1186/s40064-015-0793-1. [View Abstract]
Patel N, Tong L, Ahn C, Singal AG, Gupta S. Post-polypectomy Guideline Adherence: Importance of Belief in Guidelines, Not Guideline Knowledge or Fear of Missed Cancer. Dig Dis Sci. 2015 Oct;60(10):2937-45. Epub 2015 May 7. doi: 10.1007/s10620-015-3685-x. [View Abstract]
Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Womens Health (Larchmt). 2015 Feb;24(2):138-43. Epub 2014 Dec 18. doi: 10.1089/jwh.2014.4954. [View Abstract]
Persing S, Jerome MA, James TA, Callas P, Mace J, Sowden M, et al. Surgical margin reporting in breast conserving surgery: Does compliance with guidelines affect re-excision and mastectomy rates? Breast. 2015 Oct;24(5):618-22. Epub 2015 Jul 18. doi: 10.1016/j.breast.2015.06.007. [View Abstract]
Pertuz S, McDonald ES, Weinstein SP, Conant EF, Kontos D. Fully Automated Quantitative Estimation of Volumetric Breast Density from Digital Breast Tomosynthesis Images: Preliminary Results and Comparison with Digital Mammography and MR Imaging. Radiology. 2016 Apr;279(1):65-74. Epub 2015 Oct 21. doi: 10.1148/radiol.2015150277. [View Abstract]
Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in U.S. Women, 2000-2012. JAMA. 2018 Jan 9;319(2):154-164. Erratum in: JAMA. 2018 Feb 20;319(7):724. doi: 10.1001/jama.2017.19130. [View Abstract]
Pruitt SL, Leonard T, Zhang S, Schootman M, Halm EA, Gupta S. Physicians, clinics, and neighborhoods: multiple levels of influence on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1346-55. Epub 2014 Apr 14. doi: 10.1158/1055-9965.EPI-13-1130. [View Abstract]
Pruitt SL, Werner CL, Borton EK, Sanders JM, Balasubramanian BA, Barnes A, et al. Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System. Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1398-1406. Epub 2018 Sep 5. doi: 10.1158/1055-9965.EPI-17-0912. [View Abstract]
Rauscher GH, Murphy AM, Qiu Q, Dolecek TA, Tossas K, Liu Y, et al. The "Sweet Spot" Revisited: Optimal Recall Rates for Cancer Detection With 2D and 3D Digital Screening Mammography in the Metro Chicago Breast Cancer Registry. AJR Am J Roentgenol. 2021 Apr;216(4):894-902. Epub 2021 Feb 10. doi: 10.2214/AJR.19.22429. [View Abstract]
Ray S, Chen L, Keller BM, Chen J, Conant EF, Kontos D. Association between Breast Parenchymal Complexity and False-Positive Recall From Digital Mammography Versus Breast Tomosynthesis: Preliminary Investigation in the ACRIN PA 4006 Trial. Acad Radiol. 2016 Aug;23(8):977-86. Epub 2016 May 25. doi: 10.1016/j.acra.2016.02.019. [View Abstract]
Rodriguez SA, Higashi RT, Betts AC, Ortiz C, Tiro JA, Luque AE, et al. Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV. J Low Genit Tract Dis. 2021 Jan 1;25(1):43-47. doi: 10.1097/LGT.0000000000000578. [View Abstract]
Rogers NA, Gupta S, Cuthbert JA. Continuous furosemide infusion in the management of ascites. J Investig Med. 2012 Apr;60(4):671-5. doi: 10.2310/JIM.0b013e31824963f1. [View Abstract]
Roth RG, Maidment AD, Weinstein SP, Roth SO, Conant EF. Digital breast tomosynthesis: lessons learned from early clinical implementation. Radiographics. 2014 Jul-Aug;34(4):E89-102. doi: 10.1148/rg.344130087. [View Abstract]
Rutter CM, Greenlee RT, Johnson E, Stark A, Weinmann S, Kamineni A, et al. Prevalence of colonoscopy before age 50. Prev Med. 2015 Mar;72:126-9. Epub 2015 Jan 4. doi: 10.1016/j.ypmed.2014.12.028. [View Abstract]
Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, et al. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. Epub 2017 Nov 17. doi: 10.1158/1055-9965.EPI-17-0378. [View Abstract]
Samples LS, Rendi MH, Frederick PD, Allison KH, Nelson HD, Morgan TR, et al. Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens. Breast. 2017 Aug;34:34-43. Epub 2017 May 3. doi: 10.1016/j.breast.2017.04.004. [View Abstract]
Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, et al. Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol. 2018 Sep;25(9):1118-1127. Epub 2018 Feb 9. doi: 10.1016/j.acra.2017.12.028. [View Abstract]
Schapira MM, Sprague BL, Klabunde CN, Tosteson AN, Bitton A, Chen JS, et al. Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice. J Gen Intern Med. 2016 Oct;31(10):1148-55. Epub 2016 Jun 1. doi: 10.1007/s11606-016-3726-y. [View Abstract]
Schifferdecker KE, Tosteson ANA, Kaplan C, Kerlikowske K, Buist DSM, Henderson LM, et al. Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". J Gen Intern Med. 2020 Jun;35(6):1654-1660. Epub 2019 Dec 2. doi: 10.1007/s11606-019-05560-z. [View Abstract]
Seitz HH, Gibson L, Skubisz C, Forquer H, Mello S, Schapira MM, et al. Effects of a risk-based online mammography intervention on accuracy of perceived risk and mammography intentions. Patient Educ Couns. 2016 Oct;99(10):1647-56. Epub 2016 May 4. doi: 10.1016/j.pec.2016.05.005. [View Abstract]
Seitz HH, Schapira MM, Gibson LA, Skubisz C, Mello S, Armstrong K, et al. Explaining the effects of a decision intervention on mammography intentions: The roles of worry, fear and perceived susceptibility to breast cancer. Psychol Health. 2018 May;33(5):682-700. Epub 2017 Oct 26. doi: 10.1080/08870446.2017.1387261. [View Abstract]
Selby K, Baumgartner C, Levin TR, Doubeni CA, Zauber AG, Schottinger J, et al. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017 Oct 17;167(8):565-575. Epub 2017 Oct 10. doi: 10.7326/M17-1361. [View Abstract]
Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, et al. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018 Oct 2;169(7):439-447. Epub 2018 Sep 18. doi: 10.7326/M18-0244. [View Abstract]
Selby K, Jensen CD, Levin TR, Lee JK, Schottinger JE, Zhao WK, et al. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing. Clin Gastroenterol Hepatol. 2020 Sep 30:S1542-3565(20)31372-0. Epub ahead of print. doi: 10.1016/j.cgh.2020.09.042. [View Abstract]
Selby K, Jensen CD, Zhao WK, Lee JK, Slam A, Schottinger JE, et al. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study. Clin Transl Gastroenterol. 2019 Feb;10(2):e00010. doi: 10.14309/ctg.0000000000000010. [View Abstract]
Selby K, Levine EH, Doan C, Gies A, Brenner H, Quesenberry C, et al. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis. Gastroenterology. 2019 Dec;157(6):1494-1505. Epub 2019 Aug 22. doi: 10.1053/j.gastro.2019.08.023. [View Abstract]
Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, et al. Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. Epub 2017 Oct 6. doi: 10.1158/1055-9965.EPI-17-0531. [View Abstract]
Shiyanbola OO, Sprague BL, Hampton JM, Dittus K, James TA, Herschorn S, et al. Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ. Cancer. 2016 Sep 15;122(18):2810-8. Epub 2016 May 31. doi: 10.1002/cncr.30105. [View Abstract]
Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J. Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud. 2016 Aug;2:51-64. Epub 2016 Sep 26. [View Abstract]
Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, et al. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May;113(5):746-754. Epub 2018 Feb 27. doi: 10.1038/s41395-018-0023-x. [View Abstract]
Singal AG, Gupta S, Lee J, Halm EA, Rutter CM, Corley D, et al. Importance of determining indication for colonoscopy: implications for practice and policy original. Clin Gastroenterol Hepatol. 2014 Dec;12(12):1958-63.e1-3. doi: 10.1016/j.cgh.2014.09.028. [View Abstract]
Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, et al. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389. [View Abstract]
Singal AG, Gupta S, Tiro JA, Skinner CS, McCallister K, Sanders JM, et al. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer. 2016 Feb 1;122(3):456-63. Epub 2015 Nov 4. doi: 10.1002/cncr.29770. [View Abstract]
Singal AG, Patibandla S, Obi J, Fullington H, Parikh ND, Yopp AC, et al. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 Sep;19(9):1925-1932.e1. Epub 2020 Sep 10. doi: 10.1016/j.cgh.2020.09.014. [View Abstract]
Skinner CS, Ahn C, Halm EA, Bishop WP, McCallister K, Sanders JM, et al. Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk. Prev Med. 2017 Sep;102:20-23. Epub 2017 Jun 15. doi: 10.1016/j.ypmed.2017.06.014. [View Abstract]
Skinner CS, Gupta S, Halm EA, Wright S, McCallister K, Bishop W, et al. Development of the Parkland-UT Southwestern Colonoscopy Reporting System (CoRS) for evidence-based colon cancer surveillance recommendations. J Am Med Inform Assoc. 2016 Mar;23(2):402-6. Epub 2015 Aug 8. doi: 10.1093/jamia/ocv081. [View Abstract]
Smith LN, Makam AN, Darden D, Mayo H, Das SR, Halm EA, et al. Acute Myocardial Infarction Readmission Risk Prediction Models: A Systematic Review of Model Performance. Circ Cardiovasc Qual Outcomes. 2018 Jan;11(1):e003885. doi: 10.1161/CIRCOUTCOMES.117.003885. [View Abstract]
Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, et al. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 Apr;283(1):59-69. Epub 2017 Feb 28. doi: 10.1148/radiol.2017161519. [View Abstract]
Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, et al. Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology. 2014 Feb;270(2):354-61. Epub 2013 Oct 28. doi: 10.1148/radiol.13131063. [View Abstract]
Sprague BL, Coley RY, Kerlikowske K, Rauscher GH, Henderson LM, Onega T, et al. Assessment of Radiologist Performance in Breast Cancer Screening Using Digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2020 Mar 2;3(3):e201759. doi: 10.1001/jamanetworkopen.2020.1759. [View Abstract]
Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, et al. Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med. 2016 Oct 4;165(7):457-464. Epub 2016 Jul 19. doi: 10.7326/M15-2934. [View Abstract]
Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014 Sep 12;106(10):dju255. doi: 10.1093/jnci/dju255. [View Abstract]
Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, et al. Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies. Am J Epidemiol. 2015 Jun 15;181(12):956-69. Epub 2015 May 5. doi: 10.1093/aje/kwu474. [View Abstract]
Sprague BL, Kerlikowske K, Bowles EJA, Rauscher GH, Lee CI, Tosteson ANA, et al. Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2019 Jun 1;111(6):629-632. doi: 10.1093/jnci/djy210. [View Abstract]
Sprague BL, McLaughlin V, Hampton JM, Newcomb PA, Trentham-Dietz A. Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Res Treat. 2013 Aug;141(1):145-54. Epub 2013 Aug 25. doi: 10.1007/s10549-013-2670-3. [View Abstract]
Sprague BL, Miglioretti DL, Lee CI, Perry H, Tosteson AAN, Kerlikowske K. New mammography screening performance metrics based on the entire screening episode. Cancer. 2020 Jul 15;126(14):3289-3296. Epub 2020 May 6. doi: 10.1002/cncr.32939. [View Abstract]
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015 Feb 3;162(3):157-66. doi: 10.7326/M14-0692. [View Abstract]
Sprague BL, Vacek PM, Herschorn SD, James TA, Geller BM, Trentham-Dietz A, et al. Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort. Breast Cancer Res Treat. 2019 Feb;174(1):227-235. Epub 2018 Nov 17. doi: 10.1007/s10549-018-5048-8. [View Abstract]
Sprague BL, Vacek PM, Mulrow SE, Evans MF, Trentham-Dietz A, Herschorn SD, et al. Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes. Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):80-88. Epub 2020 Oct 20. doi: 10.1158/1055-9965.EPI-20-0889. [View Abstract]
Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, et al. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res Treat. 2019 Jun;175(2):519-523. Epub 2019 Feb 22. doi: 10.1007/s10549-019-05167-2. [View Abstract]
Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. J Clin Oncol. 2015 Oct 1;33(28):3137-43. Epub 2015 Aug 17. doi: 10.1200/JCO.2015.60.8869. [View Abstract]
Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1147-58. Epub 2014 Jun 10. doi: 10.1158/1055-9965.EPI-13-1217. [View Abstract]
Tollivoro TA, Jensen CD, Marks AR, Zhao WK, Schottinger JE, Quinn VP, et al. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2019 Jan;89(1):168-176.e3. Epub 2018 Aug 23. doi: 10.1016/j.gie.2018.08.023. [View Abstract]
Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, et al. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med. 2016 Apr;31(4):372-9. doi: 10.1007/s11606-015-3552-7. [View Abstract]
Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, et al. Consequences of false-positive screening mammograms. JAMA Intern Med. 2014 Jun;174(6):954-61. doi: 10.1001/jamainternmed.2014.981. [View Abstract]
Trentham-Dietz A, Alagoz O, Chapman C, Huang X, Jayasekera J, van Ravesteyn NT, et al. Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts. PLoS Comput Biol. 2021 Jun 17;17(6):e1009020. doi: 10.1371/journal.pcbi.1009020. [View Abstract]
Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, et al. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. Breast Cancer Res Treat. 2018 Feb;168(1):229-239. Epub 2017 Nov 28. doi: 10.1007/s10549-017-4582-0. [View Abstract]
Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, et al. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Ann Intern Med. 2016 Nov 15;165(10):700-712. Epub 2016 Aug 23. doi: 10.7326/M16-0476. [View Abstract]
Valeri L, Chen JT, Garcia-Albeniz X, Krieger N, VanderWeele TJ, Coull BA. The Role of Stage at Diagnosis in Colorectal Cancer Black-White Survival Disparities: A Counterfactual Causal Inference Approach. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):83-9. Epub 2015 Oct 26. doi: 10.1158/1055-9965.EPI-15-0456. [View Abstract]
van den Broek JJ, van Ravesteyn NT, Mandelblatt JS, Cevik M, Schechter CB, Lee SJ, et al. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology. Med Decis Making. 2018 Apr;38(1_suppl):112S-125S. doi: 10.1177/0272989X17743244. [View Abstract]
Vatovec C, Erten MZ, Kolodinsky J, Brown P, Wood M, James T, et al. Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society. Crit Rev Eukaryot Gene Expr. 2014;24(4):281-6. doi: 10.1615/critreveukaryotgeneexpr.2014011495. [View Abstract]
Veal CT, Hart V, Lakoski SG, Hampton JM, Gangnon RE, Newcomb PA, et al. Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ. J Cancer Surviv. 2017 Jun;11(3):320-328. Epub 2017 Jan 5. doi: 10.1007/s11764-016-0590-z. [View Abstract]
Weiss JE, Goodrich M, Harris KA, Chicoine RE, Synnestvedt MB, Pyle SJ, et al. Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy. J Am Coll Radiol. 2017 Feb;14(2):198-207.e2. Epub 2016 Oct 13. doi: 10.1016/j.jacr.2016.08.017. [View Abstract]
Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, et al. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 Aug;26(8):820-827. Epub 2017 Feb 8. doi: 10.1089/jwh.2016.6076. [View Abstract]
Wernli KJ, Bowles EA, Knerr S, Leppig KA, Ehrlich K, Gao H, et al. Characteristics Associated with Participation in ENGAGED 2 - A Web-based Breast Cancer Risk Communication and Decision Support Trial. Perm J. 2020 Dec;24:1-4. doi: 10.7812/TPP/19.205. [View Abstract]
Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks Associated With Anesthesia Services During Colonoscopy. Gastroenterology. 2016 Apr;150(4):888-94; quiz e18. Epub 2015 Dec 18. doi: 10.1053/j.gastro.2015.12.018. [View Abstract]
Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Reply. Gastroenterology. 2016 Sep;151(3):564. Epub 2016 Aug 3. doi: 10.1053/j.gastro.2016.07.041. [View Abstract]
Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, et al. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1230-7. Epub 2014 May 3. doi: 10.1158/1055-9965.EPI-13-1360. [View Abstract]
Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, et al. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 Aug;292(2):311-318. Epub 2019 Jun 4. doi: 10.1148/radiol.2019182475. [View Abstract]
Wheeler CM. The natural history of cervical human papillomavirus infections and cervical cancer: gaps in knowledge and future horizons. Obstet Gynecol Clin North Am. 2013 Jun;40(2):165-76. Epub 2013 May 8. doi: 10.1016/j.ogc.2013.02.004. [View Abstract]
White AJ, Weinberg CR, O'Meara ES, Sandler DP, Sprague BL. Airborne metals and polycyclic aromatic hydrocarbons in relation to mammographic breast density. Breast Cancer Res. 2019 Feb 13;21(1):24. doi: 10.1186/s13058-019-1110-7. [View Abstract]
Wood ME, Sprague BL, Oustimov A, Synnstvedt MB, Cuke M, Conant EF, et al. Aspirin use is associated with lower mammographic density in a large screening cohort. Breast Cancer Res Treat. 2017 Apr;162(3):419-425. Epub 2017 Feb 4. doi: 10.1007/s10549-017-4127-6. [View Abstract]
Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015 Mar;60(3):681-91. Epub 2015 Mar 5. doi: 10.1007/s10620-015-3600-5. [View Abstract]
Zheng Y, Keller BM, Ray S, Wang Y, Conant EF, Gee JC, et al. Parenchymal texture analysis in digital mammography: A fully automated pipeline for breast cancer risk assessment. Med Phys. 2015 Jul;42(7):4149-60. doi: 10.1118/1.4921996. [View Abstract]
Ziv E, Tice JA, Sprague B, Vachon CM, Cummings SR, Kerlikowske K. Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. PLoS One. 2017 Jan 20;12(1):e0168601. doi: 10.1371/journal.pone.0168601. [View Abstract]
Zuckerman SP, Conant EF, Keller BM, Maidment AD, Barufaldi B, Weinstein SP, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736. Epub 2016 Jul 28. doi: 10.1148/radiol.2016160366. [View Abstract]
Zuckerman SP, Sprague BL, Weaver DL, Herschorn SD, Conant EF. Multicenter Evaluation of Breast Cancer Screening with Digital Breast Tomosynthesis in Combination with Synthetic versus Digital Mammography. Radiology. 2020 Dec;297(3):545-553. Epub 2020 Oct 13. doi: 10.1148/radiol.2020200240. [View Abstract]